News & Articles

Reserve your place today for talks on topics ranging from food fraud, spatial infiltration and CRISPR to antibody and AAV gene therapies

Explore topics from in vitro diagnostics, flow cytometry, pharmaceutical solid-phase microextraction, liquid handling and much more

An MIT team has created polymers that replicate the structure of mucins, the molecules that give mucus its unique antimicrobial properties

The program was developed in partnership with Color Health, Inc., a California-based leader in distributed healthcare services

Amanda Kulwicki, Global Brand Manager at Thermo Fisher Scientific, discusses how her team ensures sample integrity with confidence

Lateral flow assays are empowering the fight against COVID-19 and in this article, experts in the field tell us more about this technology, highlighting recent advances and challenges

This collaboration enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency

Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR

Explore topics from immuno-oncology, Raman spectroscopy, in vitro diagnostics, and clinical research

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant

The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools

Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing

The assay has the ability to sequence and surveil evolution of virus mutations over time and geography

This partnership aims to offer an accelerated route to market rapid test technologies

Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test

Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall